Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation.
about
A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future PerspectivesMolecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis.Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.
P2860
Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Local delivery of rolipram, a ...... rotein-induced bone formation.
@ast
Local delivery of rolipram, a ...... rotein-induced bone formation.
@en
type
label
Local delivery of rolipram, a ...... rotein-induced bone formation.
@ast
Local delivery of rolipram, a ...... rotein-induced bone formation.
@en
prefLabel
Local delivery of rolipram, a ...... rotein-induced bone formation.
@ast
Local delivery of rolipram, a ...... rotein-induced bone formation.
@en
P2093
P1476
Local delivery of rolipram, a ...... rotein-induced bone formation.
@en
P2093
Chizumi Nomura
Koichi Yano
Kunio Takaoka
Masatoshi Hoshino
Mitsunari Kim
Shigeyuki Wakitani
Susumu Taguchi
Yoshinori Kadoya
Yoshio Tokuhara
Yuuki Imai
P2888
P356
10.1007/S00774-009-0103-5
P577
2009-06-25T00:00:00Z